Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506335 | SCV000603956 | uncertain significance | not specified | 2017-04-10 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000670754 | SCV000795649 | uncertain significance | Tay-Sachs disease | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000670754 | SCV003034356 | uncertain significance | Tay-Sachs disease | 2022-10-24 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 87 of the HEXA protein (p.Arg87Trp). This variant is present in population databases (rs573269641, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with HEXA-related conditions. ClinVar contains an entry for this variant (Variation ID: 439785). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The tryptophan amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000670754 | SCV001461557 | uncertain significance | Tay-Sachs disease | 2020-09-16 | no assertion criteria provided | clinical testing |